Recurrent implantation failure

Early Pregnancy

Volumn , Issue , 2010, Pages 213-226

  MacKlon, Nick S ^a   Boomsma, Carolien M ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927043679     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511777851.021     Document Type: Chapter

References (94)

1. The European IVF-monitoring Program 2005 Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod 2005; 20: 1158-76.
2. Boomsma CM, Kavelaars A, Eijkemans MJ et al. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod 2009; 24: 1427-35.
3. Macklon NS, Geraedts JPM, Fauser BCJM. Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update 2002; 8: 333-43.
4. Tan BK, Vandekerckhove P, Kennedy P, Keay SD. Investigation and current management of recurrent IVF treatment failure in the UK. Br J Obstet Gynaecol 2005; 112: 773-80.
5. Templeton A, Morris JK, Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 1996; 348: 1402-6.
6. Croucher CA, Lass A, Margara R, Winston RM. Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles. Hum Reprod 1998; 13: 403-8.
7. Garcia Velasco J, Sanchez E. Implantation failure. In NS Macklon, IA Greer, EAP Steegers (eds.), Textbook of Periconceptional Medicine. Informa, London: Informa Healthcare, 2009.
8. Aboulghar MA, Mansour RT, Serour GI. Controversies in the modern management of hydrosalpinx. Hum Reprod Update 1998; 4: 882-90.
9. Johnson NP, Mak W, Sowter MC. Laparoscopic salpingectomy for women with hydrosalpinges enhances the success of IVF: a Cochrane review. Hum Reprod 2002; 17: 543.
10. Strandell A, Lindhard A, Waldenstrom U, Thorburn J. Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial. Human Reprod 2001; 16: 2403-10.
11. Strandell A. The patient with hydrosalpinx. In NS Macklon (ed.), IVF in the Medically Complicated Patient: A Guide to Management. London: Taylor and Francis.
12. Kontoravdis A, Makrakis E, Pantos K et al. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril 2006; 86: 1642-9.
13. Oliveira JB, Martins AM, Baruffi RL et al. Increased implantation and pregnancy rates obtained by placing the tip of the transfer catheter in the central area of the endometrial cavity. Reprod Biomed Online 2004; 9: 435-41.
14. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91: 1215-23.
15. Coulam CB, Kay C, Jeyendran RS. Role of p53 codon 72 polymorphism in recurrent pregnancy loss. Reprod Biomed Online 2006; 12: 378-82.
16. Bellver J, Soares SR, Alvarez C et al. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod 2008; 23: 278-84.
17. Navot D, Scott RT, Droesch K et al. The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril 1991; 55: 114-18.
18. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. New Engl J Med 1999; 340: 1796-9.
19. Dey SK, Lim H, Das SK et al. Molecular cues to implantation. Endocr Rev 2004; 25: 341-73.
20. Hoozemans DA, Schats R, Lambalk CB, Homburg R, Hompes PG. Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reprod Biomed Online 2004; 9: 692-715.
21. Talbi S, Hamilton AE, Vo KC et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006; 147: 1097-121.
22. Mirkin S, Nikas G, Hsiu JG, Diaz J, Oehninger S. Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab 2004; 89: 5742-52.
23. Horcajadas JA, Riesewijk A, Polman J et al. Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod 2005; 11: 195-205.
24. Macklon NS, Van der Gaast MH, Hamilton AE et al. The effect of stimulation with recombinant FSH and GnRH antagonists on endometrial gene expression in the absence of luteal support. Reprod Sci 2008; 15: 357-65.
25. Van der Gaast MH, Macklon NS, Beier-Hellwig K et al. The feasibility of a less invasive method to assess endometrial maturation - comparison of simultaneously obtained uterine secretion and tissue biopsy. BJOG 2009; 116(2): 304-12.
26. Boomsma CM, Kavelaars A, Eijkemans MJC et al. 2009 Cytokine profiling in endometrial secretions: a non invasive window on endometrial receptivity. Reprod Biomed Online 2009; 18: 85-94.
27. Baart EB, Martini E, Eijkemans MJC et al. Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 2007; 22: 980-8.
28. Raziel A, Friedler S, Schachter M et al. Increased frequency of female partner chromosomal abnormalities in patients with high-order implantation failure after in vitro fertilization. Fertil Steril 2002; 78: 515-19.
29. Pehlivan T, Rubio C, Rodrigo L et al. Preimplantation genetic diagnosis by fluorescence in situ hybridization: clinical possibilities and pitfalls. J Soc Gynecol Investig 2003; 10: 315-22.
30. Los FJ, Van Opstal D, van den Berg C. The development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model. Hum Reprod Update 2004; 10: 79-94.
31. Devroey P, Fauser BC. Preimplantation aneuploidy screening: a research tool for now. Lancet 2007; 370 (9604): 1985-6.
32. Mercader A, Garcia-Velasco JA, Escudero E et al. Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: a 5-year follow-up study. Fertil Steril 2003; 80: 1162-8.
33. Spandorfer SD, Pascal P, Parks J et al. Autologous endometrial coculture in patients with IVF failure: outcome of the first 1,030 cases. J Reprod Med 2004; 49: 463-7.
34. Sallam HN, Sadek SS, Agameya AF. Assisted hatching -a meta-analysis of randomized controlled trials. J Assist Reprod Genet 2003; 20: 332-42.
35. Dayal MB, Dubey A, Frankfurter D, Peak D, Gindoff PR. Second cycle: to hatch or not to hatch? Fertil Steril 2007; 88(3): 718-20.
36. Seif MM, Edi-Osagie EC, Farquhar C et al. Assisted hatching on assisted conception (IVF & ICSI). Cochrane Database Syst Rev 2006; 1: CD001894.
37. Boomsma CM, Macklon NS. What can the clinician do to improve implantation? Reprod Biomed Online 2006; 13: 845-55.
38. Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995; 10: 2432-7.
39. Macklon NS, Fauser BC. Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil 2000; 55: 101-8.
40. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006; 27: 170-207.
41. Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab 2004; 15: 84-90.
42. Ma Wg, Song H, Das SK, Paria BC, Dey SK. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci USA 2003; 100: 2963-8.
43. Kolibianakis EM, Bourgain C, Papanikolaou EG et al. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod 2005; 20: 2453-6.
44. Fauser BC, Devroey P, Yen SS et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 1999; 14: 2681-6.
45. Fauser BC, Macklon NS. Medical approaches to ovarian stimulation for infertility. In JF Strauss, RL Barbieri (eds.), Yen and Jaffe's Reproductive Endocrinology. 5th edition. Philadelphia: Elsevier Saunders, 2004, pp. 965-1012.
46. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 2003; 88: 166-73.
47. Fanchin R, Righini C, Olivennes F et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod 1998; 13: 1968-74.
48. Buckett WM. A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer. Fertil Steril 2006; 85: 728-34.
49. Coroleu B, Barri PN, Carreras O et al. The influence of the depth of embryo replacement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study. Hum Reprod 2002; 17: 341-6.
50. Romundstad LB, Romundstad PR, Sunde A et al. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod 2006; 21: 2353-8.
51. Buckett WM. A meta-analysis of ultrasound-guided versus clinical touch embryo transfer. Fertil Steril 2003; 80: 1037-41.
52. Liversedge NH, Turner A, Horner PJ et al. The influence of bacterial vaginosis on in-vitro fertilization and embryo implantation during assisted reproduction treatment. Hum Reprod 1999; 14: 2411-15.
53. Korn AP, Bolan G, Padian N et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995; 85: 387-90.
54. Salim R, Ben Shlomo I, Colodner R, Keness Y, Shalev E. Bacterial colonization of the uterine cervix and success rate in assisted reproduction: results of a prospective survey. Hum Reprod 2002; 17: 337-40.
55. Kuo HC, Hsu CC, Wang ST, Huang KE. Aspirin improves uterine blood flow in the peri-implantation period. J Formosan Med Assoc 1997; 96: 253-7.
56. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database System Rev 2005; 2: CD002859.
57. Di Nisio M, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database System Rev 2005; 2: CD004734.
58. Stern C, Chamley L, Norris H, Hale L, Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 2003; 80: 376-83.
59. Rubinstein M, Marazzi A, Polak DF. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double- blind placebo-controlled assay. Fertil Steril 1999; 71: 825-9.
60. Duvan CI, Ozmen B, Satiroglu H, Atabekoglu CS, Berker B. Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. J Assist Reprod Genet 2006; 23: 15-21.
61. Pakkila M, Rasanen J, Heinonen S et al. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo- controlled double-blind study. Hum Reprod 2005; 20: 2211-14.
62. Urman B, Mercan R, Alatas C et al. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet 2000; 17: 586-90.
63. Waldenstrom U, Hellberg D, Nilsson S. Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertil Steril 2004; 81: 1560-4.
64. Daya S. Is there a benefit of low-dose aspirin in assisted reproduction? Curr Opin Obstet Gynecol 2006; 18: 313-18.
65. Coulam CB, Stern JJ, Soenksen DM, Britten S, Bustillo M. Comparison of pulsatility indices on the day of oocyte retrieval and embryo transfer. Hum Reprod 1995; 10: 82-4.
66. Battaglia C, Salvatori M, Maxia N et al. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod 1999; 14: 1690-7.
67. Battaglia C, Regnani G, Marsella T et al. Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum Reprod 2002; 17: 659-65.
68. Lee TH, Wu MY, Chen MJ et al. Nitric oxide is associated with poor embryo quality and pregnancy outcome in in vitro fertilization cycles. Fertil Steril 2004; 82: 126-31.
69. Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chemistry 1990; 33: 2933-42.
70. Goswami SK, Das T, Chattopadhyay R et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 2004; 19: 2031-5.
71. Healey S, Tan SL, Tulandi T, Biljan MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2003; 80: 1325-9.
72. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003; 18: 1588-97.
73. Mitwally MF, Casper RF. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Social Gynecol Invest 2004; 11: 406-15.
74. Luck MR, Jeyaseelan I, Scholes RA. Ascorbic acid and fertility. Biol Reprod 1995; 52: 262-6.
75. Luck MR, Zhao Y. Identification and measurement of collagen in the bovine corpus luteum and its relationship with ascorbic acid and tissue development. J Reprod Fertil 1993; 99: 647-52.
76. Griesinger G, Franke K, Kinast C et al. Ascorbic acid supplement during luteal phase in IVF. J Assist Reprod Genet 2002; 19: 164-8.
77. Miyazaki S, Tanebe K, Sakai M et al. Interleukin 2 receptor gamma chain (gamma(c)) knockout mice show less regularity in estrous cycle but achieve normal pregnancy without fetal compromise. Am J Reprod Immunol 2002; 47: 222-30.
78. Ledee-Bataille N, Bonnet-Chea K, Hosny G et al. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005; 83: 598-605.
79. Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005; 84: 980-4.
80. Boomsma CM, Eijkemans MJ, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database System Rev 2007; 1: CD005996.
81. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstetrics Gynecol 2002; 99: 135-44.
82. Geva E, Amit A, Lerner-Geva L et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am J Reprod Immunol 2000; 43: 36-40.
83. Ando T, Suganuma N, Furuhashi M et al. Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. J Assist Reprod Genet 1996; 13: 776-81.
84. Rai R, Sacks G, Trew G. Natural killer cells and reproductive failure - theory, practice and prejudice. Hum Reprod 2005; 20: 1123-6.
85. Lintsen AM, Pasker-de Jong PC, de Boer EJ et al. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod 2005; 20: 1867-75.
86. Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update 2005; 11: 43-57.
87. Macklon NS (ed.) IVF in the Medically Complicated Patient. London: Taylor and Francis, 2005.
88. Zenzes MT, Krishnan S, Krishnan B, Zhang H, Casper RF. Cadmium accumulation in follicular fluid of women in in vitro fertilization-embryo transfer is higher in smokers. Fertil Steril 1995; 64: 599-603.
89. Paszkowski T, Clarke RN, Hornstein MD. Smoking induces oxidative stress inside the Graafian follicle. Hum Reprod 2002; 17: 921-5.
90. Zenzes MT, Wang P, Casper RF. Cigarette smoking may affect meiotic maturation of human oocytes. Hum Reprod 1995; 10: 3213-17.
91. The Practice Committee of the American Society for Reproductive Medicine Smoking and Infertility. Fertil Steril 2006; 86: S172-7.
92. Norman RJ, Clark AM. Obesity and reproductive disorders: a review. Reprod Fertil Dev 1998; 10: 55-63.
93. Boxmeer JC, Brouns MM, Lindemans J et al. Folic acid treatment affects oocyte environment. J Social Gynecol Invest 2005; 12: 24A.
94. Boxmeer JC, Smit M, Weber RFA et al. Seminal plasma cobalamin significantly correlates with sperm concentration. J Social Gynecol Invest 2006; 11: 406-15.